1 Followers USX:DGX - Quest Diagnostics, Inc. (USD 73.34) Quest Diagnostics, Inc.
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance

USD 73.34    -4.110 (-5.31%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

3 Apr 2020


3 Apr 2020

Day Change: -4.110 (-5.31%)

52 Wk Range: 73.02 - 118.58

Day's Range: 73.02 - 77.43

Last Volume: 1,595,669

Current Yield: 2.93%

Projected Yield: 2.93%

Open: USD 76.92

3 Apr 2020

Metric DGX S.Median
Beta 0.76 0.77
VaR 17.04 46.1
E.Shortfall 30.41 76.92
Liquidity 1.35M 22.95K


3 Apr 2020

PE: 12.882

Market Cap: 10B

Price Over Book: 1.793

Price Over Sales: 1.32

Return On Assets: 6.5%

Return On Equity: 13.9%

NAV Over Price: [Friends Only]


CEO: Stephen H. Rusckowski

Headquarters: Secaucus

Employees: 46,000

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company's Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, gene-based and esoteric testing, and drugs-of-abuse testing, as well as anatomic pathology services, and related services and insights. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum, and Care360 brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, and phlebotomists in physician offices. Its Diagnostic Solutions segment offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Madison, New Jersey.